Table 2.
Odds of testing positive uOR (95% CI) | P-value | Odds of testing positive aORa (95% CI) | P-value | |
---|---|---|---|---|
Demographics | ||||
Age group | ||||
16-44 | Reference | Reference | ||
45-64 | 1.33 (1.00-1.76) | .050 | 1.75 (1.25-2.44) | .001 |
≥65 | 1.37 (0.86-2.21) | .189 | 2.78 (1.49-5.16) | .001 |
Sex | ||||
Female | Reference | Reference | ||
Male | 1.70 (1.30-2.22) | .0001 | 1.60 (1.19-2.16) | .002 |
Vital Signs | ||||
Pulse Oximetry | ||||
> 97 % | Reference | Reference | ||
≤ 97 % | 1.53 (1.15-2.03) | .004 | 1.39 (1.00-1.92) | .048 |
Temperature | ||||
≤ 98.9° F | Reference | Reference | ||
≥ 99.0° F | 2.92 (2.20-3.88) | <.0001 | 3.06 (2.23-4.20) | <.0001 |
Pulse | ||||
≥ 100 | Reference | Reference | ||
< 100 | 0.79 (0.55-1.13) | .197 | 0.90 (0.60-1.36) | .625 |
Respiratory Rate | ||||
< 17 | Reference | Reference | ||
≥ 17 | 1.14 (0.87-1.49) | .352 | 0.99 (0.73 - 1.32) | .926 |
Systolic Blood Pressure | ||||
> 120 | Reference | Reference | ||
≤ 120 | 1.24 (0.95-1.63) | .116 | 1.64 (1.20-2.24) | .002 |
COMORBIDITIES b | ||||
Heart Disease c | ||||
Yes | 0.64 (0.38-1.06) | .083 | 0.56 (0.31-1.02) | .058 |
Diabetes mellitus d | ||||
No | Reference | Reference | ||
Yes | 0.86 (0.51-1.45) | .578 | 0.88 (0.47-1.62) | .676 |
Chronic Lung Disease e | ||||
No | Reference | Reference | ||
Yes | 0.57 (0.33 - 0.96) | .036 | 0.55 (0.30-1.02) | .057 |
Asthma f | ||||
No | Reference | Reference | ||
Yes | 0.64 (0.41-0.98) | .040 | 0.91 (0.55-1.48) | .698 |
RISK ASSESSMENT QUESTIONNAIRE g | ||||
Q1. High-risk Medical Issues | ||||
No | Reference | Reference | ||
Yes | 0.74 (0.55-0.99) | .040 | 0.81 (0.56-1.18) | .267 |
Q2. Recent High-risk Travel | ||||
No | Reference | Reference | ||
Yes | 1.22 (0.67-2.22) | .519 | 1.34 (0.70-2.56) | .374 |
Q3. COVID Close Contact | ||||
No | Reference | Reference | ||
Yes | 1.28 (0.98-1.67) | .074 | 1.56 (1.15-2.10) | .004 |
Q4. COVID at Large Gathering | ||||
No | Reference | Reference | ||
Yes | 1.97 (1.19-3.26) | .008 | 1.92 (1.10-3.34) | .022 |
Q5. Decrease in Taste/Smell | ||||
No | Reference | Reference | ||
Yes | 2.70 (1.97-3.71) | <.0001 | 2.83 (2.01-3.99) | <.0001 |
Risk Stratification | ||||
Low risk | Reference | − | − | |
High risk | 1.15 (0.82-1.63) | .415 | − |
Abbreviations: uOR, Unadjusted Odds Ratio; aOR, Adjusted Odds Ratio; 95% CI, 95% Confidence Interval.
Bolded text signifies statistically significant P-values (P < .05).
Adjusted for all covariates of interest: age, gender, vital signs (pulse oximetry, temperature, pulse, respiratory rate, systolic blood pressure), comorbidities (heart disease, diabetes, chronic lung disease, asthma), and other risk factors (question 1-5).
Comorbidities were derived from patient problem list. Low-risk patients who did not report comorbidities in the risk assessment questionnaire may have had comorbidities documented in the problem list.
Heart disease ICD-10 codes I20-I25 or I30-I52 in problem list.
Diabetes ICD-10 codes E10-E14 in problem list.
Chronic lung disease ICD-10 codes J40-J44 or J46-J47 in problem list.
Asthma ICD-10 codes J45 in problem list.
Full text of questions 1-5 listed in methods.